Kabra Drugs Limited Press Release Oct 09 2025
Filed with BSE · · 5 pages · English
With reference to the captioned subject and pursuant to the provisions of Regulation 30 and other applicable regulations of the Listing Regulations, please be informed that based on the recommendation of the Nomination and Remuneration Committee and Audit Committee of the Company, the Board of Directors at their meeting held today, i.e., 08th October 2025 have considered and approved taken note of
Earlier from Kabra Drugs
- Kabra Drugs Limited Press Release Oct 08 2025
- Kabra Drugs Limited Press Release Oct 01 2025
- Kabra Drugs Limited Press Release Sep 30 2025
- Kabra Drugs Limited Press Release Sep 26 2025
- Kabra Drugs Limited Press Release Sep 24 2025
Later from Kabra Drugs
- Kabra Drugs Limited Press Release Oct 13 2025
- Kabra Drugs Limited Press Release Nov 05 2025
- Kabra Drugs Limited Press Release Nov 17 2025
- Kabra Drugs Limited Press Release Dec 03 2025
- Kabra Drugs Limited Press Release Dec 05 2025
Follow Kabra Drugs into a list and get an email when it puts out news.
Follow Kabra Drugs